Apex Biotechnology Corp. (TPE:1733)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.50
-0.90 (-3.06%)
At close: Mar 9, 2026
-7.01%
Market Cap 2.85B
Revenue (ttm) 1.96B
Net Income (ttm) 151.31M
Shares Out 99.95M
EPS (ttm) 1.50
PE Ratio 19.00
Forward PE n/a
Dividend 1.20 (4.08%)
Ex-Dividend Date Jun 11, 2025
Volume 262,433
Average Volume 190,647
Open 29.10
Previous Close 29.40
Day's Range 28.30 - 29.10
52-Week Range 26.40 - 38.70
Beta 0.32
RSI 34.06
Earnings Date Mar 13, 2026

About Apex Biotechnology

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is based in Hsinchu City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1733
Full Company Profile

Financial Performance

In 2024, Apex Biotechnology's revenue was 1.85 billion, an increase of 10.48% compared to the previous year's 1.68 billion. Earnings were 128.00 million, an increase of 10.55%.

Financial Statements

News

There is no news available yet.